Results

Merck & Co. Inc.

05/24/2021 | Press release | Distributed by Public on 05/24/2021 04:46

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) in Combination With Chemotherapy as First-Line Treatment for Certain Patients With Esophageal Cancer or[...]